The US HHS has launched a $500m initiative to accelerate the development of universal vaccines targeting viruses with ...

Eli Lilly’s strong quarterly results were overshadowed by CVS’s decision to favour Novo Nordisk’s Wegovy over Zepbound.

4D Molecular Therapeutics (4DMT) has received regenerative medicine advanced therapy (RMAT) designation from the US Food and ...

Whilst 2025 outlooks include cost impact from existing tariffs, companies have not adjusted their guidance for future ...

As scientists explore treating genetic disorders before birth, the promise of foetal gene therapy is growing—but there are ...

The UK MHRA has granted marketing authorisation to Bavarian Nordic's Vimkunya vaccine for preventing the chikungunya virus.

Repare Therapeutics has entered into an out-licensing agreement with Canadian biotechnology firm DCx for discovery platforms ...

The astronomical rise in popularity of GLP-1RAs in recent years has led to a shortage, prompting users to turn to compounders ...

While the pharmaceutical industry is currently exempt from US tariffs, there is an increased risk to the stability of the ...

The situation began to escalate after Trump’s trade policy announcement on 5 April.

The FDA has granted approval for AbbVie’s 15mg Rinvoq (upadacitinib) to treat adults with giant cell arteritis (GCA).

Data from the NERO study investigating Zejula in mesothelioma was presented at the American Association of Cancer Research ...